Tiziana Life Sciences PLC Director/PDMR Shareholding (8160X)

TIDMTILS

RNS Number : 8160X

Tiziana Life Sciences PLC

02 May 2019

For immediate release

Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

New York/London, 1 May 2019 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 1 May 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought ordinary shares of nominal value 3p each in the capital of the Company, as set out below, following prior consultation with the Takeover Panel in relation to Note 11 to Rule 9.1 of the City Code on Takeovers and Mergers.

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 
 1.   Details of PDMR / person closely associated 
 a)   Name                                   Gabriele Cerrone/Panetta 
                                              Partners Limited 
     -------------------------------------  --------------------------------- 
 2.   Reason for the notification: On market acquisition 
     ------------------------------------------------------------------------ 
 a)   Position / status                      Executive Chairman 
     -------------------------------------  --------------------------------- 
 b)   Initial notification /amendment        Initial notification 
     -------------------------------------  --------------------------------- 
 3.   Details of the issuer 
     ------------------------------------------------------------------------ 
 a)   Name                                   Tiziana Life Sciences plc 
     -------------------------------------  --------------------------------- 
 b)   LEI                                    213800CED47HI8PIOB36 
     -------------------------------------  --------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------ 
 a)   Description of the financial           Ordinary Shares of nominal 
       instrument                             value 3p each 
     -------------------------------------  --------------------------------- 
 b)   Identification code of the Financial   GB00BKWNZY55 
       Instrument 
     -------------------------------------  --------------------------------- 
 c)   Nature of the transaction              On market acquisition of 
                                              ordinary shares 
     -------------------------------------  --------------------------------- 
 d)   Price(s) and volume(s)                   Price: GBP0.60; Volume: 10,000 
     -------------------------------------  --------------------------------- 
 e)   Aggregated information 
       - Aggregated volume                     10,000 
       - Price                                 GBP6,000.00 
     -------------------------------------  --------------------------------- 
 f)   Date of the transaction                1 May 2019 
     -------------------------------------  --------------------------------- 
 g)   Place of the transaction               XLON 
     -------------------------------------  --------------------------------- 
 

As a result of this transaction Mr Cerrone's interests in the underlying ordinary shares of the Company increases from 64,204,425 (47.036%) to 64,214,425 (47.056%). Mr Cerrone's interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 534,021 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

Contacts:

 
 
  Tiziana Life Sciences plc                          [phone] 
  Gabriele Cerrone, Chairman and founder             2853 
Cairn Financial Advisers LLP (Nominated adviser)   [phone] 
 Liam Murray / Jo Turner                            0883 
Stockdale Securities (Broker)                      [phone] 
 Antonio Bossi / Andy Crossley                      6100 
 

5243926 v1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBRGDULGGBGCB

(END) Dow Jones Newswires

May 02, 2019 02:00 ET (06:00 GMT)